Evaluation of a novel rash scale and a serum proteomic predictor in a randomized phase II trial of sequential or concurrent cetuximab and pemetrexed in previously treated non-small cell lung cancer

Overview of attention for article published in BMC Cancer, January 2014

Altmetric Badge

Mentioned by

facebook: 1 Facebook page

Citations

dimensions_citation: 4 Dimensions

Readers on

mendeley: 42 Mendeley

Summary Facebook Dimensions citations

So far, Altmetric has seen 1 public wall post.

Health5C - Comprehensive Consistent Collaborative Citizen Care, 05 Jan 2014

Background: Candidate predictive biomarkers for epidermal growth factor receptor inhibitors (EGFRi), skin rash and serum…